Opzelura approval date?

See the DrugPatentWatch profile for Opzelura

When was Opzelura (ruxolitinib cream) approved?

Opzelura was first approved by the FDA on September 18, 2020 for the treatment of nonsegmental vitiligo and mild to moderate atopic dermatitis in patients who meet specific criteria. [1]

Was Opzelura approved on different dates for different uses?

Yes. Opzelura’s approval history includes initial FDA approval and later label expansions for additional patient populations and conditions. The main FDA approval date commonly cited for Opzelura is September 18, 2020 for the first approval of the product. [1]

Where can I verify Opzelura’s FDA approval date?

You can confirm the FDA approval date and review related approval and patent/exclusivity context on DrugPatentWatch.com. [1]

Sources
[1] https://www.drugpatentwatch.com/knowledge-base/opzelura/